Genolution Inc. (KOSDAQ:225220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,352.00
-28.00 (-2.03%)
At close: Sep 3, 2026

Genolution Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
10,0319,4047,1369,76138,085
Revenue Growth
14.42%31.79%-26.90%-74.37%-
Gross Profit
3,1043,4422,3004,45725,907
Operating Income
-7,439-8,642-9,164-7,09114,737
Net Income
-4,661-11,643-6,826-5,51214,602
Earnings Per Share
-257.82-644.48-378.00-300.43768.91
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
26,82827,91933,22043,46446,390
Total Debt
24,02624,03424,27024,14816,885
Net Cash (Debt)
2,8023,8868,95019,31629,504
Net Cash Growth
-57.11%-56.58%-53.67%-34.53%-
Net Cash Per Share
154.99215.09495.631052.901563.01

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-3,008-7,012-1,433-1,13613,551
Capital Expenditures
-277.26-296.3-12,125-6,805-22,506
Free Cash Flow
-3,285-7,308-13,558-7,940-8,955
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
30.94%36.60%32.23%45.66%68.03%
Operating Margin
-74.15%-91.89%-128.42%-72.65%38.70%
Pretax Margin
-56.28%-133.83%-94.89%-68.16%45.26%
Profit Margin
-46.46%-123.80%-95.65%-56.46%38.34%
FCF Margin
-32.75%-77.71%-190.00%-81.34%-23.51%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
----5.97
PS Ratio
2.463.655.637.542.29